Companies

The Smart Way to Manage Myopia in Children

Myopia has been recognized as a significant public health issue. Its prevalence continues to rise, and it is estimated that it will affect more than half of the global population by 2050.¹ High myopia can lead to retinal pathologies,² making timely and proper management essential. Educating parents, guardians, and caregivers, conducting early screenings, and implementing targeted treatments can contribute to good ocular health outcomes.

MiYOSMART lenses utilize the innovative D.I.M.S. (Defocus Incorporated Multiple Segments) technology, which won the Gold Prize at the International Exhibition of Inventions in Geneva in 2018³ and the Silmo d'Or Award in the Vision category at the Silmo Paris Optical Fair in 2020.⁴ The goal of treatment with MiYOSMART lenses is to slow the progression of myopia in a simple, safe, effective, and non-invasive way⁵⁶⁷⁸.

1. Holden B.A., Fricke T.R., Wilson D.A., Jong M., Naidoo K.S., Sankaridurg P., Wong T.Y., Naduvilath T.J., Resniko S. Global Prevalence of Myopia and High Myopia and Temporal Trends from 2000 through 2050. American Academy of Ophthalmology. 05/2016, vol.123, no. 5, p.1036–1042.

2. Mark A. Bullimore, Eric R. Ritchey, Sunil Shah, Nicolas Leveziel, Rupert R.A. Bourne, D. Ian Flitcroft, The Risks and Benefits of Myopia Control, Ophthalmology, 2021, ISSN 0161-6420, https://doi.org/10.1016/j.ophtha.2021.04.032

3 .Grand Prize, Grand Award and Special Gold Medal at the 46th International Exhibition of Inventions of Geneva in 2018https://inventions-geneva.ch/en/winners/(accessed 15.06.2023).

4. SILMO d’Or 2020.https://en.silmoparis.com/SILMO-d-OR/SILMO-d-Or-Awards-archives/20202(accessed 15.06.2023).

5. Patent protected in China under patent number ZL 201310628174.8, in Hong Kong under patent number 1210838, in US under patent number 10268050 & 11029540.

6. Lam CSY, Tang WC, Tse DY, Lee RPK, Chun RKM, Hasegawa K, Qi H, Hatanaka T, To CH. Defocus Incorporated Multiple Segments (DIMS) spectacle lenses slow myopia progression: a 2-year randomized clinical trial. British Journal of Ophthalmology. Published Online First: 29 May 2019. https://doi.org/10.1136/bjophthalmol-2018-313739

7. Lam CSY, Tang WC, Lee PH, et al. Myopia control effect of defocus incorporated multiple segments (DIMS) spectacle lens in Chinese children: results of a 3-year follow-up study. British Journal of Ophthalmology. Published Online First: 17 March 2021.https://doi.org/10.1136/bjophthalmol-2020-317664

8. Lam, C.S.Y., Tang, W.C., Zhang, H.Y. et al. Long-term myopia control effect and safety in children wearing DIMS spectacle lenses for 6 years. Sci Rep 13, 5475 (2023). https://doi.org/10.1038/s41598-023-32700-7